The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Smeeta SinhaLisa J GouldSagar U NigwekarThomas E SerenaVincent BrandenburgSharon M MoeGeorge AronoffDinesh K ChatothJeffrey L HymesStephan MillerClaire PadgettKevin J CarrollJoan PerellóAlex GoldGlenn M ChertowPublished in: Clinical kidney journal (2021)
This randomized, placebo-controlled Phase 3 clinical trial will examine the efficacy and safety of SNF472 in patients who have ulcerated calciphylaxis lesions. Patient recruitment is ongoing.